Rebound hyperglycemia was observed with both intermediate (neutral protamine hagedorn) and long-acting (protamine zinc iletin) insulins, and the range of insulin doses at which the disorder developed overlapped previously determined therapeutic doses for these insulins in the cat.
Rebound hyperglycemia
protamine hagedorn
Rebound hyperglycemia
protamine zinc iletin